Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Reducing the Risk of Ulcerative Colitis-Associated Cancer
NCT04767984Phase 2Active, not recruiting
- Sponsor
- Northwestern University
- Start
- Sep 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in ulcerative colitis (UC), colorectal cancer (CRC), sponsored by Northwestern University. Started Sep 2021; status: active, not recruiting.
02
Drugs
atorvastatin
03
Conditions
ulcerative colitis (UC)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04767984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04767984.